ATE490789T1 - Konzentrationsunabhängige reaktionsfähigkeit besitzende mri-kontrastmittel - Google Patents

Konzentrationsunabhängige reaktionsfähigkeit besitzende mri-kontrastmittel

Info

Publication number
ATE490789T1
ATE490789T1 AT06753455T AT06753455T ATE490789T1 AT E490789 T1 ATE490789 T1 AT E490789T1 AT 06753455 T AT06753455 T AT 06753455T AT 06753455 T AT06753455 T AT 06753455T AT E490789 T1 ATE490789 T1 AT E490789T1
Authority
AT
Austria
Prior art keywords
concentration
contrast agents
mri contrast
response capacity
independent response
Prior art date
Application number
AT06753455T
Other languages
English (en)
Inventor
Silvio Aime
Enzo Terreno
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of ATE490789T1 publication Critical patent/ATE490789T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT06753455T 2005-04-29 2006-04-28 Konzentrationsunabhängige reaktionsfähigkeit besitzende mri-kontrastmittel ATE490789T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103567A EP1716870A1 (de) 2005-04-29 2005-04-29 Kontrastmittel für Kernspintomographie mit konzentrationsunabhängiger Empfanglichkeit
PCT/EP2006/004023 WO2006117166A2 (en) 2005-04-29 2006-04-28 Mri contrast agents endowed with concentration independent responsiveness

Publications (1)

Publication Number Publication Date
ATE490789T1 true ATE490789T1 (de) 2010-12-15

Family

ID=35976704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06753455T ATE490789T1 (de) 2005-04-29 2006-04-28 Konzentrationsunabhängige reaktionsfähigkeit besitzende mri-kontrastmittel

Country Status (6)

Country Link
US (1) US8784778B2 (de)
EP (2) EP1716870A1 (de)
AT (1) ATE490789T1 (de)
DE (1) DE602006018723D1 (de)
ES (1) ES2357624T3 (de)
WO (1) WO2006117166A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006242129A1 (en) 2005-05-02 2006-11-09 Genzyme Corporation Gene therapy for spinal cord disorders
PT3520823T (pt) 2005-05-02 2021-09-16 Genzyme Corp Terapia genética para distúrbios neurometabólicos
US7967507B2 (en) * 2008-03-14 2011-06-28 The United States of America as represented by the Secretary of Commerce, NIST Dimensional reference for tomography
US10039716B2 (en) * 2013-03-13 2018-08-07 Mallinckrodt Llc Liposomal cisplatin compositions for cancer therapy
WO2017096042A1 (en) 2015-12-01 2017-06-08 Massachusetts Institute Of Technology Ph-sensitive polymeric compositions, kits, and methods
WO2017147418A1 (en) 2016-02-24 2017-08-31 Ohio State Innovation Foundation Methods and devices for contrast agent magnetic resonance imaging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040245A1 (en) * 1995-06-07 1996-12-19 Immunomedics, Inc. Improved delivery of diagnostic and therapeutic agents to a target site
US5780010A (en) * 1995-06-08 1998-07-14 Barnes-Jewish Hospital Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
US6638508B2 (en) * 1995-12-21 2003-10-28 Yeda Research And Development Co., Ltd. Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system
CA2322344A1 (en) * 1999-12-08 2001-06-08 Mallinckrodt Inc. Non-covalent bioconjugates useful for magnetic resonance imaging
US6673333B1 (en) * 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
EP1302465A1 (de) * 2001-10-11 2003-04-16 BRACCO IMAGING S.p.A. Verbesserte MRI-Bildgebung mittels umkehrbares binding zu einem paramagnetischen Komplex
US7279150B2 (en) * 2002-01-24 2007-10-09 Barnes-Jewish Hospital Chelating agents with lipophilic carriers
EP1466629A1 (de) * 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducte zwischen NMR Vershibungsreagenzen und Substraten mit austauschbaren Protonen für die "CEST" Anwendung

Also Published As

Publication number Publication date
DE602006018723D1 (de) 2011-01-20
EP1879625A2 (de) 2008-01-23
ES2357624T3 (es) 2011-04-28
EP1716870A1 (de) 2006-11-02
EP1879625B1 (de) 2010-12-08
WO2006117166A3 (en) 2007-04-19
US20090022668A1 (en) 2009-01-22
WO2006117166A2 (en) 2006-11-09
US8784778B2 (en) 2014-07-22

Similar Documents

Publication Publication Date Title
Li et al. Molecular magnetic resonance imaging with Gd (III)-based contrast agents: challenges and key advances
Goshi et al. Nitric oxide detection methods in vitro and in vivo
Pierre et al. Comparing strategies in the design of responsive contrast agents for magnetic resonance imaging: a case study with copper and zinc
Wang et al. Cucurbit [6] uril is an ultrasensitive 129 Xe NMR contrast agent
Davies et al. Environmentally responsive MRI contrast agents
Meldrum et al. A xenon-based molecular sensor assembled on an MS2 viral capsid scaffold
De Leon-Rodriguez et al. Responsive MRI agents for sensing metabolism in vivo
Que et al. Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine
Sherry et al. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging
Swierczewska et al. High-sensitivity nanosensors for biomarker detection
Jang et al. Cu2+-responsive bimodal (optical/MRI) contrast agent for cellular imaging
Ali et al. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI
Goodfellow et al. Tracking and quantification of magnetically labeled stem cells using magnetic resonance imaging
Zhang et al. Preliminary demonstration of in vivo quasi‐steady‐state CEST postprocessing—Correction of saturation time and relaxation delay for robust quantification of tumor MT and APT effects
Liu et al. Diaper-based wearable SERS sensing system with a silver nano dual-structure composite hydrogel for the detection of biomarkers and pH in urine
Barandov et al. Molecular magnetic resonance imaging of nitric oxide in biological systems
Bonnet et al. Metal-based environment-sensitive MRI contrast agents
Xu et al. Caspase-3-triggered intracellular gadolinium nanoparticle formation for T1-weighted magnetic resonance imaging of apoptosis in vivo
Gündüz et al. Ratiometric method for rapid monitoring of biological processes using bioresponsive MRI contrast agents
Geng et al. Supramolecular design based activatable magnetic resonance imaging
Koudrina et al. Exploring the unique contrast properties of aptamer–gadolinium conjugates in magnetic resonance imaging for targeted imaging of thrombi
ATE519505T1 (de) Reaktive paramagnetische kontrastmittel für magnetresonanzbildgebung
Pavuluri et al. pH imaging using chemical exchange saturation transfer (CEST) MRI
DE602006018723D1 (de) Konzentrationsunabhängige reaktionsfähigkeit besitzende mri-kontrastmittel
Zhang et al. 129Xe hyper-CEST/19F MRI multimodal imaging system for sensitive and selective tumor cells detection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties